2011
DOI: 10.3791/3183
|View full text |Cite
|
Sign up to set email alerts
|

Isolation of CD133+ Liver Stem Cells for Clonal Expansion

Abstract: Liver stem cell, or oval cells, proliferate during chronic liver injury, and are proposed to differentiate into both hepatocytes and cholangiocytes. In addition, liver stem cells are hypothesized to be the precursors for a subset of liver cancer, Hepatocellular carcinoma. One of the primary challenges to stem cell work in any solid organ like the liver is the isolation of a rare population of cells for detailed analysis. For example, the vast majority of cells in the liver are hepatocytes (parenchymal fraction… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
14
0

Year Published

2012
2012
2019
2019

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(15 citation statements)
references
References 29 publications
(32 reference statements)
0
14
0
Order By: Relevance
“…Based on the evidence in the prostate alone, it appears to be clear that not all CD133 pos cells are stem cells and that CD133 neg cells may also possess stem-like properties. Several additional studies support this hypothesis by demonstrating that CD133 was expressed in differentiated epithelial cells in a variety of other organs including the pancreas [ 71 , 72 ], liver [ 73 , 74 ], colon [ 56 , 75 ], gastric contents [ 76 ], sweat glands [ 77 ], salivary and lacrimal glands [ 77 , 78 ], uterus [ 77 ], and kidneys [ 79 ]. Altogether, these studies indicate that the overall expression of human CD133 expands beyond stem cell populations and although it appears to negatively correlate with cell differentiation, it is likely not a regulator of stemness in most tissues [ 75 ].…”
Section: Cd133 As a Stem Cell Markermentioning
confidence: 99%
“…Based on the evidence in the prostate alone, it appears to be clear that not all CD133 pos cells are stem cells and that CD133 neg cells may also possess stem-like properties. Several additional studies support this hypothesis by demonstrating that CD133 was expressed in differentiated epithelial cells in a variety of other organs including the pancreas [ 71 , 72 ], liver [ 73 , 74 ], colon [ 56 , 75 ], gastric contents [ 76 ], sweat glands [ 77 ], salivary and lacrimal glands [ 77 , 78 ], uterus [ 77 ], and kidneys [ 79 ]. Altogether, these studies indicate that the overall expression of human CD133 expands beyond stem cell populations and although it appears to negatively correlate with cell differentiation, it is likely not a regulator of stemness in most tissues [ 75 ].…”
Section: Cd133 As a Stem Cell Markermentioning
confidence: 99%
“…The existence of cancer stem cells (CSCs) in malignant tumors has been proposed for some decades, and much evidence supports this hypothesis. Hepatic cancer stem cells (HCSCs) have been identified and isolated from HCCs (Rountree et al 2011;Mikhail and He 2011;Cao et al 2011;Cheung et al 2011;Jia et al 2012;Yoon 2012;Shen and Cao 2012;Piao et al 2012;, and characterized by specific properties such as expression of CD133 (Suetsugu et al 2006;Yin et al 2007;Ma et al 2007), CD44, CD133 (Zhu et al 2010), CD90 (Yang et al 2008), EpCAM (Epithelial cell adhesion molecule) (Yamashita et al 2008(Yamashita et al , 2009), CD13 (Haraguchi et al 2010), OV6 (Yang et al 2008) and ALDH (Aldehyde hydrogenase) (Ma et al 2008).…”
Section: Introductionmentioning
confidence: 99%
“…Femur, tibia, and lumbar vertebras from mice were cut aseptically in 1.5 mm small pieces, rinsed in PBS, and placed in digestion media consisting 5 mg collagenase, 5 mg pronase, and 1 mg DNAse for 45 minutes at 37° C (19). Following digestion, single cell suspension was passed through a 70 µm strainers twice.…”
Section: Methodsmentioning
confidence: 99%